| Literature DB >> 25636565 |
Gonca E Karahan1, Yvonne J H de Vaal1, Dave L Roelen1, Rico Buchli2, Frans H J Claas1, Sebastiaan Heidt3.
Abstract
For the quantification of HLA-specific memory B cells from peripheral blood of sensitized individuals, a limited number of methods are available. However, none of these are capable of detecting memory B cells directed at HLA class II molecules. Since the majority of antibodies that occur after transplantation appear to be specific for HLA class II, our aim was to develop an assay to detect and quantify HLA class II-specific memory B cells from peripheral blood. By using biotinylated soluble HLA class II molecules as detection agent, we were able to develop an HLA class II-specific memory B cell ELISPOT assay. The assay was validated using B cell-derived hybridomas that produce human monoclonal antibodies directed at specific HLA class II molecules. In pregnancy-immunized females, we found memory B cell frequencies ranging from 25 to 756 spots per 10(6) B cells specific for the immunizing paternal HLA class II molecules, whereas in non-immunized males no significant spot formation was detected. Here, we present a novel ELISPOT assay for quantifying HLA class II-specific memory B cells from peripheral blood. This technique provides a unique tool for monitoring the HLA class II-specific memory B cell pool in sensitized transplant recipients.Entities:
Keywords: Chronic rejection; HLA antibodies; Kidney transplantation; Luminex; Pregnancy-immunized women
Mesh:
Substances:
Year: 2015 PMID: 25636565 DOI: 10.1016/j.humimm.2015.01.014
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850